Screener
Cumberland Pharmaceuticals CPIX Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $166.46K-56.3% | $9.13M-22.0% | $13.68M+31.1% | $8.29M-8.7% | $380.8K-96.1% | ||
| —— | $7.2M-30.0% | $11.44M+35.2% | $7.3M-5.9% | -$1.63M-120% | ||
| $772.16K-7.8% | $1.46M+12.6% | $1.55M+19.9% | $1.25M-4.0% | $837.4K-20.9% | ||
| $2.55M-4.1% | $2.55M+3.7% | $4.04M+21.4% | $2.57M-3.9% | $2.66M-3.6% | ||
| $3.33M-5.0% | $12.26M+17.7% | $15.05M+22.6% | $10.26M-4.8% | $3.5M-67.8% | ||
| -$3.16M-1.3% | -$3.13M-342% | -$1.37M+25.6% | -$1.97M-16.0% | -$3.12M-204% | ||
| -1,898.7%-1,079pp | -34.3%-45.3pp | -10%+7.6pp | -23.7%-5.1pp | -819.2%-809pp | ||
| $724+53.7% | $85.84K-47.6% | $112.94K-49.4% | $109.7K-20.1% | $471-99.6% | ||
| -$3.1M-3.6% | -$3.14M-350% | -$1.39M+28.9% | -$1.94M-27.4% | -$2.99M-174% | ||
| $3.87K-31.8% | $3.87K-31.7% | $23.25K+141% | $5.67K-50.4% | $5.67K-50.4% | ||
| -$4.28M-477% | -$3.29M-362% | -$1.41M+25.8% | -$1.94M-25.7% | -$740.74K+31.8% | ||
| -2,569%-2,375pp | -36%-46.8pp | -10.3%+7.9pp | -23.4%-6.4pp | -194.5%-184pp | ||
| -$0.29-480% | -$0.22-375% | -$0.09+35.7% | -$0.13-18.2% | -$0.05+37.5% | ||
| -$3.15M-1.3% | -$1.85M-180% | -$329.31K+4.7% | $1.06M+283% | -$3.11M-2,861% | ||
| -1,894.4%-1,077pp | -20.3%-40.1pp | -2.4%+0.9pp | 12.8%+19.2pp | -817.7%-819pp | ||
| -$3.16M-1.3% | -$3.13M-342% | -$1.37M+25.6% | -$1.97M-16.0% | -$3.12M-204% |
FAQ
- What is Cumberland Pharmaceuticals's revenue?
- Cumberland Pharmaceuticals (CPIX) generated $31.3M in revenue over the trailing twelve months, down 1.1% year over year.
- Is Cumberland Pharmaceuticals profitable?
- Cumberland Pharmaceuticals is not currently profitable: it reported a net loss of $10.9M over the trailing twelve months, a -34.9% net margin.
- What are Cumberland Pharmaceuticals's profit margins?
- Gross margin is 77.2% and operating margin is -30.8%, with a -34.9% net margin.
- What is Cumberland Pharmaceuticals's earnings per share?
- Cumberland Pharmaceuticals's diluted EPS over the trailing twelve months is $-0.73.
- Where does Cumberland Pharmaceuticals's income statement data come from?
- Every line is extracted from Cumberland Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
